Kerendia (Finerenone)

Kerendia is a non-steroidal mineralocorticoid receptor antagonist (MRA) used to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospital stay for heart failure in adult individuals with chronic kidney disease associated with type 2 diabetes (T2D).

Recommended Dosage: The recommended starting dosage of Kerendia tablets is 10 mg or 20 mg orally once daily with or without food on behalf of estimated glomerular filtration rate (eGFR) and serum potassium thresholds. Kerendia dosage can be scaled up after four weeks to the target dose of 20 mg once daily, on behalf of estimated Glomerular Filtration Rate (eGFR) and serum potassium thresholds.

Those who are not capable of swallowing whole tablets, Kerendia may be crushed and mixed with water promptly prior to use and administered orally.

In case of a missed dose, the prescribed dose should be taken as quickly as possible before the very next scheduled dose. Do not take a couple of doses on the very same day to catch up for a missed dose.

• Measure serum potassium 4 weeks after initiating therapy and adjust dose; if serum potassium levels are > 4.8 to 5.0 mEq/L, initiation of Kerendia therapy may be considered with additional serum potassium monitoring within the initial 4 weeks on behalf of clinical judgment and serum potassium levels. Assess serum potassium 4 weeks following a dose adjustment and throughout therapy, and adjust the dose as required.
• Kerendia can be responsible for causing hyperkalemia. The chance of occurring hyperkalemia scales up with scaling down kidney function and is higher in all those with greater baseline potassium levels or certain other risk factors for hyperkalemia. Measure serum potassium and eGFR in all those prior to initiation of Kerendia 20 mg treatment and dose accordingly.
• The concomitant consumption of grapefruit or grapefruit juice needs to be avoided as it may be responsible for enhancing the plasma concentration of medicine finerenone.
• Prior to taking Kerendia, patients should inform their health specialist in case they are pregnant or want to become pregnant. Breastfeeding is not recommended at the time of treatment with Finerenone and for 24 hours after treatment.

What documents are required to import KERENDIA to India?

KERENDIA® (finerenone) tablets can be imported by patients or government hospitals in the name of the patients only.

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patient’s diagnostic reports.
• Patient’s ID proof (issued by the Government of India).

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the doctor.
• Import permit if applicable.

Is KERENDIA available in India?

KERENDIA® (finerenone tablets) is a prescription drug that legally requires a medical prescription to be dispensed.

Urgent Meds helps import prescription medicines on a named patient supply (NPS) basis. We provide assistance with:

• Availability of Kerendia in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.).
• Medicine price.
• Finding genuine and reliable sources from the USA, Canada, Europe, and Australia.
• Ensuring 100% transparency.

KERENDIA® can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

Urgent Meds can facilitate the supply of KERENDIA® (prescription medicines) to all locations in the world and in India after fulfilling the legal requirements (if applicable).

Please contact +1-647-818-4196 or write us at info@urgentmeds.in for Kerendia® price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Urgent Meds is proficient in sourcing KERENDIA (Cancer Treatment Medicines) from around the world and has the capability to supply it. We offer global access to the best available treatment for our customers worldwide.

Urgent Meds is committed to dispensing any valid prescription promptly. All prescriptions are dispensed and verified by registered pharmacists and are dispatched only to the patient’s address from New Delhi, India. Your health and well-being are our top priorities.

What is the Generic Name for the trade name drug Kerendia®?

Finerenone is the generic name for the trade name drug Kerendia®.

What is the Manufacturer’s Name of Kerendia®?

Kerendia® is manufactured by Bayer HealthCare Pharmaceuticals Inc.

Is Kerendia® approved by the FDA?

Yes, Kerendia® is approved by the FDA. The date of first/initial approval is July 13, 2021.

What is the dosage and form of Kerendia® supplied?

Kerendia® is supplied as a film-coated tablet in two strengths: 10 mg and 20 mg for oral administration.

What are the most common side effects of Kerendia®?

The most common side effects of Kerendia® include hypotension, hyperkalemia, and hyponatremia.

How much does Kerendia® cost in India?

The cost of Kerendia® in India can vary. To procure this CKD associated with T2D drug authentically, you can call or WhatsApp +1-647-818-4196 or send an email to info@urgentmeds.in.

What are the storage conditions of Kerendia®?

Kerendia® 10 mg/20 mg comes in bottles of 30 and 90 tablets. Store tablets at 20-25°C (68-77°F); excursions are permitted from 15-30°C (59-86°F).

Is it safe to buy Kerendia® online in India?

Yes, you can buy Kerendia® in India at the best price from Urgent Meds if Kerendia® has not been approved or is not available in your home country.